Nomenclature for parasitic diseases: cohabitation with inconsistency for how long and why?

The author surveys the early history of nomenclature for parasitic diseases or infections which led to the existing usage of synonymous names with diverse spellings for denominating the same disease entities. In order to diminish heterogeneity in nomenclatural usage, principles of the standardized nomenclature of parasitic diseases (SNOPAD) have been put forward by the World Association for the Advancement of Veterinary Parasitology. Pros and cons regarding the SNOPAD concept are discussed in seeking consensus terminology. The need for a standard nomenclature may be judged differently. SNOPAD is just a guideline based on carefully reasoned and clearly defined principles for those authors and editors dissatisfied with the existing heterogeneous and inconsistent nomenclatural usage and wish to rely on a uniform and standard disease nomenclature. The major suggestion of SNOPAD is the use solely of suffix -osis when disease name is coined from the name of a parasite taxon. Meanwhile, the proposed principles were found sensible and accepted more in the field of veterinary, less in medical parasitology. In a recent survey it has been revealed that the majority (73.8%) of 126 national language parasitological textbooks or compendia from 21 countries of Europe published since 1990 adopted consistent '-osis' disease terminology and the rest (26.2%) used a mixture of disease names ending in '-osis' and '-iasis' inconsistently. For achieving substantial shift towards the use of more consistent disease terminology, the interest and support of the parasitologists' community is required. Editorials and database producers hold the key to further progress provided they see the advantages of the use of a single name of worldwide currency for each disease entity.     

The impact on database searching arising from inconsistency in the nomenclature of parasitic diseases

The existing usage of disease names formed from the name of the parasite taxon is characterised by marked heterogeneity. This is largely due to the fact that, for coining disease names, four different suffixes, '-osis', '-iosis', '-asis' and '-iasis', are being used inconsistently. The result is that alternative terms are in use for naming the same disease, e.g. trypanosomosis and trypanosomiasis, fasciolosis and fascioliasis, ascariosis and ascariasis. Inspite of the SNOAPAD/SNOPAD guideline (1988) which proposed the principles of a uniform and standard disease nomenclature, the actual usage depends largely on tradition, educational imprinting and personal preferences, showing great variation. By using alternative disease names as search terms the author investigates in four databases the impact of nomenclatural heterogeneity on information storage and retrieval. It is evident that the existence of alternative disease names in parasitology markedly interferes with the efficacy of online data retrieval. The value of a disease name as a search term was shown to be greatly different in various databases. Until we have to coexist with an inconsistent disease terminology we need to adopt specially structured database-search techniques to ensure a proper level of precision in searching. Such possible techniques are considered.     

Expression of immunoregulatory tumor necrosis factor-like molecule TL1A in chicken chondrocyte differentiation

The proinflammatory cytokine tumor necrosis factor (TNF) alpha is not encoded in the chicken genome. However, 1 member of the TNF family, TNF-like molecule 1A (TL1A), which is an important immunoregulatory protein, has recently been characterized in chickens. In this study, chicken TL1A (chTL1A) and 1 of its receptors, decoy receptor 3 (DcR3) were found to be expressed in developing bone of 14.5-day-old chicken embryos. Chicken chondrocytes were shown to express TL1A by polymerase chain reaction (PCR) amplification of cDNA and by immunohistochemical studies. Tissue expression was localized to the epiphyeal region of tubular bones, particularly cells of the epiphyseal plate, the outer chondrocytes of the cartilage-interfacing synovia, most of the synovial cells, and the stromal fibroblastic cells of the vascular channels of the femoral head. A tissue-specific developmental function of TL1A was supported by the presence of DcR3 in the embryonic connective tissue.     

Pressure-volume index-based volume calculation of contrast medium for atlanto-occipital myelography in dogs

Subarachnoid pressure recordings were made during atlanto-occipital myelography in 45 dogs with clinical signs of spinal disease. Iohexol was injected at a dosage of 0.3 ml/kg body weight and simultaneous pressure values were recorded in the cerebellomedullary cistern. The mean subarachnoid pressure was 9 ± 3 mmHg before and 70 ± 32 mmHg at the end of administration. From the pressure change induced by the volume load, the pressure-volume index (PVI) of the subarachnoid space was calculated and found to be in close correlation with body weight and the crown-rump length (r = 0.94 and 0.87). Using the estimated PVI values, the appropriate volume of contrast medium can be calculated for an animal according to body weight. Dogs of a large body size require relatively less contrast medium than small-sized dogs (range 0.17-0.35 ml/kg). This calculated volume is unlikely to increase the subarachnoid pressure above 40 mmHg as a specific pressure limit. Using these data, simplified recommendations for the choice of contrast medium volumes have been generated.     

Partition of Cd,Cu, Pb and Zn among mineral particles during their sorption in soils

Journal of Soils and Sediments - Heterogeneity of soil mineral particles may lead to the misinterpretation of bulk sorption data on their role in metal sorption, which may be resolved through the...     

The live attenuated bovine viral diarrhea virus components of a multi-valent vaccine confer protection against fetal infection

Fetal infection with bovine virus diarrhea virus (BVDV) causes severe economic loss and virus spread in cattle. This study investigated the ability of modified live BVDV I and II components of a commercially available modified live virus (MLV) vaccine (Breed-Back FP 10, Boehringer Ingelheim Vetmedica Inc.) to prevent fetal infection and abortion, and therefore the birth of persistently infected animals. Heifers immunized with vaccine 4-8 weeks before insemination showed no adverse effects. All vaccinated animals had seroconverted to BVDV 4 weeks after immunization. Pregnant heifers were divided into two vaccination and two control groups and challenged with type I or II BVDV on days 60-90 of gestation. Seroconversion, clinical signs, immunosuppression, viremia, mortality, abortion rate, and fetal infection were studied. Post-challenge, 6/11 (type I challenged) and 8/11 (type II challenged) vaccinated heifers were free from clinical signs of BVD. Post-challenge clinical signs noted in the vaccinated groups were mild to moderate, while all unvaccinated controls had clinical signs ranging from moderate to severe. Viremia was not detected post-challenge in any of the vaccinated heifers. However, 100% of the controls were BVDV viremic on at least 1 day post-challenge. One of 22 vaccinated heifers had transient leukopenia, whereas 2/8 and 6/7 unvaccinated heifers in control groups I and II, respectively, had transient leukopenia. Type II BVDV infection led to abortion or death in 86% of unvaccinated heifers. The corresponding vaccinated group showed no deaths or abortions. All control group fetuses were infected with BVDV. The test vaccine gave 91% (type I BVDV challenged) and 100% (type II BVDV challenged) protection from fetal infection. This vaccine is safe and effective against fetal infection, abortion (type II BVDV) and the birth of persistently infected animals.     

Fun stories about Brucella: the "furtive nasty bug"

Although Brucella is responsible for one of the major worldwide zoonosis, our understanding of its pathogenesis remains in its infancy. In this paper, we summarize some of the research in progress in our laboratory that we think could contribute to a better understanding of the Brucella molecular virulence mechanisms and their regulation.     

Cytochrome P-450 Inducers and Inhibitors Interfering with Ecdysone 20-Monooxygenases and Their Activities during Postembryonic Development of Neobellieria bullata Parker

The cytochrome P-450-dependent microsomal and mitochondrial ecdysone 20-monooxygenase systems convert ecdysone into 20-hydroxyecdysone. The microsomal fraction of fat bodies of zero h wandering stage fleshfly larvae (Neobellieria bullata; Diptera: Sarcophagidae) has a high ecdysone 20- monooxygenase activity. The effects of cytochrome P-450 inhibitors were investigated in vitro on microsomal ecdysone 20-monooxygenase. Metyrapone, fenarimol and certain imidazole derivatives (KK-42, KK-110, KK-135 and PIM) are strong inhibitors. The IC₅₀ value of KK-110, which is the strongest inhibitor, is 2 × 10^?7 M. A triazolyl and two cyclopropylamine derivatives have low activity. The activities of different NADPH-cytochrome c (P-450) reductase inhibitors were also assessed; diquat dibromide is a moderate inhibitor of microsomal ecdysone 20-monooxygenase, while paraquat dichloride has no activity. In-vivo experiments with cytochrome P-450 inducers and inhibitors gave the following results: (a) fenarimol, FI-121, precocene-2 caused “permanent” first-instar larvae; (b) barbital, phenobarbital and their sodium salts caused significant delay in larval development; (c) PIM, PTM, metyrapone, KK-42, KK-135, J-2710, RH 5849 and colchicine caused moulting disturbances; (d) J-2710, PIM, PTM, KK-42, KK-135, RH 5849 and colchicine caused lethal spiracle and mandible malformation; (e) KK-110, fenarimol, barbital and phenobarbital caused precocious pupariation.